Tech Company Financing Transactions

IsoPlexis Funding Round

On 5/15/2018, IsoPlexis raised $25 million in Series C investment from Northpond Ventures, Connecticut Innovations and Ironwood Capital.

Transaction Overview

Company Name
Announced On
5/15/2018
Transaction Type
Venture Equity
Amount
$25,000,000
Round
Series C
Proceeds Purpose
Proceeds purposes were not disclosed.

Company Information

Company Status
Publicly-held
Industry
Software
Mailing Address
35 NE Industrial Rd.
Branford, CT 06405
USA
Email Address
Overview
Our proprietary single-cell multiplexing micro-immunoassay and software enable new therapeutic and diagnostic discovery opportunities. Single cell analysis facilitates determination of cellular subsets among heterogeneous cancer and immune cell populations.
Profile
IsoPlexis LinkedIn Company Profile
Social Media
IsoPlexis Company Twitter Account
Company News
IsoPlexis News
Facebook
IsoPlexis on Facebook
YouTube
IsoPlexis on YouTube

Management Team

Title
Name
Email & Social
Chairman
John Conley
  John Conley LinkedIn Profile  John Conley Twitter Account  John Conley News  John Conley on Facebook
Chairman
Rong Fan
  Rong Fan LinkedIn Profile  Rong Fan Twitter Account  Rong Fan News  Rong Fan on Facebook
Chief Executive Officer
Sean Mackay
  Sean Mackay LinkedIn Profile  Sean Mackay Twitter Account  Sean Mackay News  Sean Mackay on Facebook
Chief Financial Officer
John Strahley
  John Strahley LinkedIn Profile  John Strahley Twitter Account  John Strahley News  John Strahley on Facebook
Chief Scientific Officer
Jing Zhou
  Jing Zhou LinkedIn Profile  Jing Zhou Twitter Account  Jing Zhou News  Jing Zhou on Facebook
Vice President
Michael Kane
  Michael Kane LinkedIn Profile  Michael Kane Twitter Account  Michael Kane News  Michael Kane on Facebook
Vice President
Pat Paczkowski
  Pat Paczkowski LinkedIn Profile  Pat Paczkowski Twitter Account  Pat Paczkowski News  Pat Paczkowski on Facebook
Vice President
Cynthia Turcotte
  Cynthia Turcotte LinkedIn Profile  Cynthia Turcotte Twitter Account  Cynthia Turcotte News  Cynthia Turcotte on Facebook
VP - Bus. Development
Peter Siesel
  Peter Siesel LinkedIn Profile  Peter Siesel Twitter Account  Peter Siesel News  Peter Siesel on Facebook
VP - Engineering
Rui Zheng
  Rui Zheng LinkedIn Profile  Rui Zheng Twitter Account  Rui Zheng News  Rui Zheng on Facebook
VP - Human Resources
Carrie Carter
  Carrie Carter LinkedIn Profile  Carrie Carter Twitter Account  Carrie Carter News  Carrie Carter on Facebook
VP - Marketing
Jon Chen
  Jon Chen LinkedIn Profile  Jon Chen Twitter Account  Jon Chen News  Jon Chen on Facebook
VP - Product Management
Peter Tsiomplikas
  Peter Tsiomplikas LinkedIn Profile  Peter Tsiomplikas Twitter Account  Peter Tsiomplikas News  Peter Tsiomplikas on Facebook
VP - Sales
Verna Siu
  Verna Siu LinkedIn Profile  Verna Siu Twitter Account  Verna Siu News  Verna Siu on Facebook


 

 

Browse more venture capital transactions:

Prev: 5/15/2018: Ansun BioPharma venture capital transaction
Next: 5/15/2018: Carro venture capital transaction

 

Share this article

 


About Database of VC Transactions

We do our best to report on every notable VC transaction. VC transactions reported here are sourced from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary